Related Experiment Video
Updated: Jul 17, 2026
Isolation of Mouse Megakaryocyte Progenitors
Published on: May 20, 2021
Differentiating megakaryocytes in myelodysplastic syndromes succumb to mitochondrial derangement without caspase
Thorsten Braun1, Gabrielle Carvalho, Jennifer Grosjean
1INSERM, Unit 848, F-94805 Villejuif, France.
Abstract:
Myelodysplastic syndromes (MDS) constitute a preneoplastic condition in which potentially malignant cancer stem cells continuously die during differentiation. This MDS-associated cell death often involves caspase-3 activation, yet can also occur without caspase activation, for instance in differentiating megakaryocytes (MK). We investigated, the mechanisms through which MK from MDS patients undergo premature cell death. While polyploid, mature MK from healthy subjects or MDS patients manifested caspase-3 activation during terminal differentiation, freshly isolated, immature MK from MDS died without caspase-3 activation. Similarly, purified bone marrow CD34(+) cells from MDS patients that were driven into MK differentiation in vitro died without caspase-3 activation at an immature stage, before polyploidization. The premature death of MDS MK was accompanied by the mitochondrial release of cytochrome c, Smac/DIABLO and endonuclease G, a caspase-independent death effector, as well loss of the mitochondrial membrane potential and plasma membrane phosphatidylserine exposure before definitive loss of viability. Thus, a stereotyped pattern of mitochondrial alterations accompanies differentiation-associated MK death in MDS.
Insights
Myelodysplastic syndromes (MDS) cause immature megakaryocytes (MK) to die prematurely via caspase-independent pathways. This involves mitochondrial damage, distinguishing it from mature MK death in MDS and healthy individuals.
Area of Science:
- Hematology
- Cancer Biology
- Cell Death Mechanisms
Background:
- Myelodysplastic syndromes (MDS) are preneoplastic conditions characterized by ineffective hematopoiesis.
- MDS involves premature death of hematopoietic stem cells during differentiation.
- Cell death in MDS can be caspase-dependent or independent, particularly in megakaryocytes (MK).
Purpose of the Study:
- To investigate the mechanisms of premature cell death in megakaryocytes (MK) from myelodysplastic syndromes (MDS) patients.
- To differentiate between caspase-dependent and independent death pathways in MDS MK.
- To identify specific molecular events associated with MDS MK death during differentiation.
Main Methods:
- Comparison of mature and immature MK from MDS patients and healthy controls.
- In vitro differentiation of purified bone marrow CD34(+) cells from MDS patients.
- Analysis of caspase-3 activation, mitochondrial release of death effectors (cytochrome c, Smac/DIABLO, endonuclease G), mitochondrial membrane potential, and phosphatidylserine exposure.
Main Results:
- Mature MK from both MDS patients and healthy subjects showed caspase-3 activation during terminal differentiation.
- Immature MK freshly isolated from MDS patients, and in vitro differentiated MDS CD34(+) cells, died prematurely without caspase-3 activation.
- MDS MK death involved mitochondrial release of cytochrome c, Smac/DIABLO, and endonuclease G, alongside loss of mitochondrial membrane potential and phosphatidylserine exposure.
Conclusions:
- A stereotyped pattern of caspase-independent mitochondrial alterations accompanies differentiation-associated premature death of immature MK in MDS.
- This mechanism of cell death in immature MDS MK differs from the terminal differentiation death observed in mature MK.
- Understanding these pathways is crucial for targeting MDS progression and improving therapeutic strategies.
